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benign myoepithelioma of the parotid gland. Through 1985, only 42 other cases
had been reported in the literature: three malignant and 39 benign. Fewer than
100 cases had been reported through 1993. The number of case reports of myoepit-
heliomas is increasing as pathologists have become more aware of their existence.
This uncommon tumor is most commonly diagnosed in the parotid gland and in the
minor salivary glands of the palate. The complex and varied morphologic expression
of neoplastic myoepithelium have attracted numerous investigators who have pre-
sented valuable but often contradictory data. It is our opinion that these tumors
are not as rare as is generally believed, but they are simply not well recognized.
Together with a review of the literature, consideration are presented on the clinical
evaluation, differential diagnosis and treatment of these lesions.c 2005 Elsevier Ltd. All rights reserved.
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5Introduction
Salivary gland neoplasms composed exclusively of
myoepithelial cells (myoepitheliomas) are unusual
and intriguing. Myoepitheliomas of salivary glands
are extremely rare, comprising approximately only741-9409/$ - see front matter c 2005 Elsevier Ltd. All rights reser
oi:10.1016/j.ooe.2005.02.004
* Corresponding author. Tel.: +39 432 559455; fax: +39 432
59868.
E-mail address: m.politi@med.uniud.it (M. Politi).1–1.5% of all salivary gland tumours.1–4 Their
histopathologic features, immunohistochemical
profile, and clinical behavior are not well charac-
terized. A majority of the myoepitheliomas de-
scribed in the literature has been benign, and the
malignant counterpart (myoepithelial carcinoma)
has been recognized recently.5 Most myoepithelio-
mas have occurred in the parotid gland and few are
located in the oral cavity.6 In 1943, Sheldon was
the first to classify tumors as myoepitheliomas
when he categorized three such tumors in a reviewved.
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ever, the precise criteria for inclusion of a tumor
in this category still remain controversial. The
complex and varied morphologic and immunophe-
notypic expression of neoplastic myoepithelium
have attracted numerous investigators who have
presented valuable but often contradictory data.
Initial diagnostic criteria for benign myoepitheli-
oma were based on the review of Barnes et al.2
and Sciubba and Brannon.3 The traditional defini-
tion included only solid (without myxochondroid
elements) tumors containing either spindle or
plasmocytoid cells. However, with the recent
appreciation of the diverse phenotypic and ultra-
structural modifications exhibited by the neoplas-
tic myoepithelial cells of different salivary gland
tumors, the morphologic spectrum of myoepitheli-
oma has expanded.Case report
A 44 year old woman presented to our university
hospital with a 6 month history of a painless swell-
ing in the region of the right parotid gland (Fig. 1).
On examination, a 2 cm diameter firm tumor mass
was palpable in the gland. The growth was well
demarcated, and it had a smooth external appear-
ance. It had a moderately firm consistency, was
fixed to neighboring tissues, and was no painfulon palpation. The oral cavity was normal on inspec-
tion. There was no associated facial weakness or
cervical lymphoadenopathy. Ultrasonography re-
vealed a roundish 25 · 20 mm mass with moder-
ately irregular borders. A solid component and
internal echoes were found in the anterior portion
of the growth. It was determined to be a cystic le-
sion because of the acoustic enhancement in its
posterior. There was a limited normal parenchyma
echo in the anterior portion of the lesion (Fig. 2).
Fine needle aspiration showed the presence of
hyperplastic glandular cells, with no cytologic
abnormalities. The cytological interpretation was
not specific. Under general anesthesia, a nodular
well-circumscribed mass was surgically excised
with a surrounding suprafacial portion of normal
parotid gland. The specimen consisted of a 3 ·
2.5 · 2 cm lobulated portion of tissue (Fig. 3). Mac-
roscopically, the tumor was solid and well-circum-
scribed. Histopathologic examination showed that
the encapsulated tumor was hypercellular (Fig.
4a) and composed of spindle (Fig. 4b) and round
cells (Fig. 4c) with clusters of epithelioid cells
(Fig. 4d). The cells had centrally located, fusiform
or round nuclei with inconspicuous nucleoli. The
cytoplasm was eosinophilic and finely granular.
The tumor had a fascicular cellular arrangement
with poor intercellular stroma. There was no necro-
sis, cellular atypia, or mitosis. Postoperatively,
there was no facial paralysis. There was no evi-
dence of disease at one year follow-up.Figure 2 Ultrasonography shows a solid component and
internal echoes in the anterior portion of the mass. A
Figure 3 Macroscopic appearance of the resected
tumor. The tumor is elastic soft and the colour is
yellowish. The surface is granular and lobulated.
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Myoepitheliomas account for fewer than 1.5% of all
salivary gland tumors. A review of the literature
through 1993 yielded approximately 100 cases.8Figure 4 Micrographs of the tumor. (a) A fibrous capsule s
present at the top (heamatoxilin–eosin stain, original magnifiThe tumor appears to be rare, and this contrast
with the active role of myoepithelial cells in the
histogenesis of several type of salivary gland tu-
mors. The number of case reports is increasing as
pathologists have become more aware of its
existence.
The most common location of myoepithelioma
of the head and neck are the parotid gland (40%)
and the palate (21%).2,9 The age and sex distribu-
tion of myoepitheliomas is similar to that of mixed
tumors. There are no distinctive clinical features
and, similar to most other salivary gland tumors,
myoepitheliomas present as asymptomatic, slowly
growing masses. Parotid lesions never cause facial
nerve dysfunction or cervical lymphadenopathy,
and those of the palate rarely ulcerate.
Fine needle aspiration cytology is a baseline
investigative tool in the assessment of patients
with salivary gland swellings. Whilst it is an accu-
rate method of distinguishing neoplastic from non-
neoplastic lesions it may not be possible to always
accurately predict a specific tumor type due to the
overlapping spectrum of cytological appearances
found in a wide variety of salivary gland neo-
plasms. This can result in a differential diagnosiseparates this tumors from the rim of the parotid tissue
cation · 60), (b) spindle-cell component (heamatoxilin–
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characteristic of a specific entity;10 as in the case
reported in the present paper. Through 1994, only
one fine needle aspiration description of myoepi-
thelioma has been reported in the literature.11
Macroscopically, myoepitheliomas appear as well-
circumscribed, frequently encapsulated tumors
that show no features distinct from mixed tumors
except for the absence of grossly myxoid or chon-
droid areas. Grossly, myoepitheliomas have a
solid, tan or yellow–tan glistening cut surface.
Parotid myoepitheliomas are usually encapsulated,
whereas those arising in the minor salivary glands
may not demonstrate a capsule. Microscopically,
they show three morphologic patterns. The spin-
dle cell pattern is the most common and consist
of a proliferation of spindle-shaped cells with
eosinophilic cytoplasm. These may be arranged
in diffuse sheets or interlacing fascicles. Tumors
are hypercellular and have limited myxoid or mu-
coid stroma. The plasmacytoid pattern shows
groups of round cells with eccentric nuclei and
eosinophilic, often hyaline-appearing cytoplasm.
These may be present in sheets of closely packed
cells or in groups of cells separated by a loose,
myxoid stroma. The third pattern shows a combi-
nation of plasmacytoid and spindle-shaped cells.
The spindle-cell pattern is most common in paro-
tid tumors.
The rarity of myoepithelioma and the varied
phenotypic expression of myoepithelial cells may
cause problems in diagnosis. Tumors consisting
predominantly of spindle-shaped myoepithelial
cells may be difficult to differentiate from
mesenchymal lesion, such as fibrous histiocytoma,
schwannoma or leiomyoma.
Ultrastructurally, they were composed of a sin-
gle cell population characterized by numerous
cytoplasmic filaments, duplicity of the basement
membrane material, and the characteristic cyto-
plasmic appearance of myoepithelial cells.12
In developing salivary glands, a common steam
cell is responsible for the development of luminal
epithelial cells and myoepithelium. Therefore, it
should be expected that proliferating neoplastic
cells in a myoepithelioma would occasionally dif-
ferentiate these luminal cells.
With immunocytochemical techniques, myo-
epithelial cells stain positive for cytokeratin,
muscle-specific actin, occasionally express S100
protein and glial fibrillary acidic protein (GFAP).
Desmin has not been demonstrated. The neoplastic
myoepithelial cells consistently demonstrate cyto-
cheratin, S100 and muscle-specific actin immuno-
reactivity, whereas the immunoreactivity for
vimentin and GFAP is more variable.13To identify myoepithelial tumors as either be-
nign or malignant on histologic grounds is difficult.
The criteria for a diagnosis of malignancy are the
presence of cytologic abnormalities, an increased
mitotic rate, and particularly an invasive growth
pattern.14 These criteria were not met in our case.
Cell type is not related to differences in biologic
behavior, recurrence rate, or the patient’s age.3
Spindle-cell myoepithelioma must be distinguished
from a pleomorphic adenoma, a nerve sheath
tumor, fibrous histiocytoma, nodular fascitis, syno-
vial sarcoma, leiomyoma and leiomyosarcoma, and
hemangiopericytoma. A plasmacytoid myoepitheli-
oma must be distinguished from a plasmacytoma.2
Myoepithelial carcinoma, known as malignant
myoepithelioma, is the malignant counterpart of
myoepithelioma. Malignant myopithelioma has
been added to the second edition of the World
Health Organization’s histological classification
of salivary gland tumor.15 The majority of myo-
epithelial carcinoma develop in a pleomorphic
adenoma.4,5,7 Myoepithelial carcinomas of the sal-
ivary gland should be classified as high-grade malig-
nancies. Overall, the prognosis of myoepithelial
carcinoma is poor.16
According to the World Health Organization’s
classification of salivary gland tumors, ‘‘Myoepit-
heliomas are characterized by a more aggressive
growth pattern than pleomorphic adenomas’’.14,17
But some authors have found that the biologic
behavior of myoepitheliomas appears to parallel
that of the pleomorphic adenoma.2,8 Others be-
lieve that myoepitheliomas are monomorphic vari-
ants of mixed tumors.3,18 It is our opinion, as well
as that of Barners et al.2 and Dardick et al.,19 that
salivary adenomas are a part of a spectrum, with
monomorphic adenoma and myoepithelioma at
the extremes and a wide range of pleomorphic ade-
nomas in between, depending on the type and
degree of gene expression that is coupled with neo-
plastic transformation. While distinguishing benign
myopithelioma from benign pleomorphic adenoma
may primarily be of academic interest, benign
myoepitheliomas should be carefully differentiated
from malignant tumors, such as malignant myoepi-
thelioma, mucoepidermoid carcinoma, and spin-
dle-cell squamous carcinoma.3,20
Surgery is the first choice of treatment for myo-
epithelial carcinomas. The high recurrence rate
suggest that initial surgery should be radical with
sufficient normal tissue margins; adjuvant chemo-
therapy and radiotherapy have not been found
helpful for treating these carcinomas.
Treatment of benign myoepitheliomas is similar
to that of mixed tumors and consist of complete
surgical removal. Most myoepitheliomas have a
108 M. Politi et al.benign course with minimal tendency for recur-
rence. Treatment should be designed as for a be-
nign salivary gland tumor with a margin of normal
uninvolved tissue being included within the surgical
excision. The recurrence rate is similar to that of
the pleomorphic adenoma.3,21
The prognosis for benign myoepitheliomas is
quite favourable, but patients should undergo reg-
ular follow-up examinations to rule out local
recurrence.Conclusions
Myoepithelioma occurs in most major and minor
salivary gland tissues, and it is generally a biologi-
cally benign lesion. By means of this case report,
we have attempted to scrutinize this entity. The
variability of the histopathologic structure of
mixed tumors and the alteration of the histochem-
ical characteristics of myoepithelial cells in tumors
from those of normal glands made identification of
tumor myoepithelial cells difficult and uncertain.
However, ultrastructural study of myoepithelial
cells established fine structural criteria on which
positive identification could be made. While myo-
epithelioma has no specific clinical features, it is
accepted pathologically as a distinct entity.
Treatment should be designed as for a benign
salivary gland tumor with a margin of normal unin-
volved tissue being included within the surgical
excision. The recurrence rate is similar to that of
the pleomorphic adenoma (15–18%).References
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